FDA Approves Jascayd (nerandomilast) Tablets for the Treatment of Progressive Pulmonary Fibrosis in Adults

Dec 23, 2025 - 16:00
 0  4
Ingelheim, Germany/Ridgefield, Connecticut, December 19, 2025 -- Boehringer Ingelheim’s Jascayd (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF)...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0